Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD)

1 March 1998

journal article
research article
Published by Oxford University Press (OUP) in Clinical and Experimental Immunology

Vol. 111 (3) , 532-535
https://doi.org/10.1046/j.1365-2249.1998.00532.x

Abstract

SUMMARY: Imbalance in Th1 and Th2 subsets and their derived cytokines seems to be involved in the immune abnormalities underlying UC and CD. CD30 is a member of the tumour necrosis factor/nerve growth receptor superfamily expressed on T cells producing Th2 cytokines and released as a soluble form. In this study high levels of soluble CD30 were found in sera of UC patients independently of disease activity. Furthermore, increased titres of soluble CD30 molecule were shown, in the same patients, by mitogen-stimulated cultures of peripheral blood mononuclear cells. Our data seem to indicate that an activation of Th2 immune response is involved in the pathogenesis of UC, but not of CD. Furthermore, this finding indicates that serum soluble CD30 measurement may be helpful for differentiating these two forms of inflammatory bowel disease.

Keywords

This publication has 33 references indexed in Scilit:

The expanding universe of T-cell subsets: Th1, Th2 and more
Published by Elsevier ,1999
Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease
Clinical and Experimental Immunology, 1997
High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints
Clinical and Experimental Immunology, 1995
Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)
Clinical and Experimental Immunology, 1995
Lymphokine Production by Human T Cells in Disease States
Annual Review of Immunology, 1994
Lymphokine Production by Human T Cells in Disease States
Annual Review of Immunology, 1994
Ki‐1 (CD30) antigen is released by Ki‐1‐positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki‐1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme‐linked immunosorbent assay
European Journal of Immunology, 1989
Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.
Gut, 1987
Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells
Nature, 1982
Cortisone in Ulcerative Colitis
BMJ, 1955